Abstract
The main bottleneck for genomic studies of tumors is the limited availability of fresh frozen (FF) samples collected from patients, coupled with comprehensive long-term clinical follow-up. This shortage could be alleviated by using existing large archives of routinely obtained and stored Formalin-Fixed Paraffin-Embedded (FFPE) tissues. However, since these samples are partially degraded, their RNA sequencing is technically challenging. In an effort to establish a reliable and practical procedure, we compared three protocols for RNA sequencing using pairs of FF and FFPE samples, both taken from the same breast tumor. In contrast to previous studies, we compared the expression profiles obtained from the two matched sample types, using the same protocol for both. Three protocols were tested on low initial amounts of RNA, as little as 100 ng, to represent the possibly limited availability of clinical samples. For two of the three protocols tested, poly(A) selection (mRNA-seq) and ribosomal-depletion, the total gene expression profiles of matched FF and FFPE pairs were highly correlated. For both protocols, differential gene expression between two FFPE samples was in agreement with their matched FF samples. Notably, although express...Continue Reading
References
Jun 1, 1972·Proceedings of the National Academy of Sciences of the United States of America·H Aviv, P Leder
Oct 28, 1999·Nucleic Acids Research·N MasudaK Okubo
Dec 7, 2007·PloS One·Silke von AhlfenMartin Schlumpberger
Jun 3, 2008·Nature Methods·Ali MortazaviBarbara Wold
Aug 20, 2008·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Joon-Yong ChungStephen M Hewitt
Feb 11, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joel S ParkerPhilip S Bernard
Mar 18, 2009·Bioinformatics·Cole TrapnellSteven L Salzberg
Jan 26, 2010·PloS One·Andrew H BeckRobert B West
Nov 22, 2011·PloS One·Ru HuangFlorian M Pauler
Apr 24, 2012·Nature·Christina CurtisSamuel Aparicio
Jul 19, 2012·PloS One·Dominick SinicropiJoffre Baker
Aug 18, 2012·PloS One·John D MorlanDominick V Sinicropi
Sep 25, 2012·Nature·UNKNOWN Cancer Genome Atlas Network
May 21, 2013·Nature Methods·Xian AdiconisJoshua Z Levin
Jul 4, 2013·Current Protocols in Molecular Biology·Dominic O'NeilMartin Schlumpberger
Aug 27, 2013·PloS One·Yan GuoYu Shyr
Apr 17, 2014·BMC Genomics·Li ShenEric Nestler
Jun 1, 2014·PloS One·Jakob HedegaardLars Dyrskjøt
Jun 4, 2014·BMC Genomics·Wei ZhaoCharles M Perou
Sep 28, 2014·Bioinformatics·Simon AndersWolfgang Huber
Dec 17, 2014·BMC Genomics·Ping LiHyung L Kim
Jul 24, 2015·Scientific Reports·Stefan GrawJeremy Chien
Jan 26, 2017·PloS One·Anna Esteve-CodinaUNKNOWN GLIOCAT Group
Citations
Sep 12, 2018·Carcinogenesis·Donovan WatzaAnn G Schwartz
Oct 23, 2019·Nature Methods·Shalom Hillel RothEli Eisenberg
May 14, 2020·Biomedicines·Maxim SorokinAnton Buzdin
Apr 18, 2019·Genome Biology·Bin XiongJi-Ping Wang
Nov 11, 2019·BMC Genomics·Xiaojing LinJun Zhao
Dec 7, 2019·BMC Cancer·Michal MarczykW Fraser Symmans
Dec 26, 2019·PeerJ·Macarena ArroyoM Gonzalo Claros
Nov 17, 2020·Frontiers in Oncology·Gislaine CurtyMiguel de Mulder Rougvie
Dec 20, 2020·Clinical Genetics·Agata SzymiczekMohammad R Akbari
Jan 29, 2021·Genes·Nadja GerberMartina Dettwiler
Nov 16, 2020·Translational Oncology·Shaham BegJuan Miguel Mosquera
Mar 16, 2021·Journal of Cellular and Molecular Medicine·Jun ChengLu Ao
Apr 19, 2021·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Maria KuksinLoïc Verlingue
Dec 12, 2020·Arthritis & Rheumatology·Jessica L TurnierJ Michelle Kahlenberg
Jun 18, 2021·BMC Genomics·Raghavendra BasavarajaRina Meidan
Dec 11, 2021·Frontiers in Molecular Biosciences·Maksim SorokinAnton Buzdin